Postdoc in Therapeutic Engineering: A 2.5-year position for an experienced postdoc is available in the research group ‘Biotherapeutic Glycoengineering and Immunology’ at the Technical University of Denmark (DTU). This role focuses on engineering human induced pluripotent stem cells (iPSCs) into NK-cells, gene-editing technologies, and the development of novel immunotherapeutics.
Postdoc in Therapeutic Engineering of iPSC-NK Cells
Designation:
Postdoctoral Researcher
| Details | Information |
|---|---|
| Research Area | Therapeutic Engineering, Glycoengineering, Immunology, Cell Biology |
| Location | Kgs. Lyngby, Denmark |
| Eligibility/Qualification | PhD in a relevant life-science discipline (cellular engineering, NK cell biology, immunology, immuno-oncology or similar) |
| Job Duration | 2.5 years |
| Starting Date | 1st May 2025 (or according to mutual agreement) |
Job Description:
The postdoc will join a collaborative team of senior scientists, postdocs, and PhD students to establish a novel iPSC-derived NK-cell platform for next-generation biotherapeutics. Key responsibilities include:
- Engineering and glycoengineering of human iPSCs into NK-cells.
- Developing gene editing and exosome-based strategies for enhanced cellular therapeutics.
- Contributing to innovation in manufacturing processes for cell-based therapies.
How to Apply:
To apply, submit a complete online application as one PDF file including:
- Application (cover letter)
- CV
- Academic Diplomas (MSc/PhD – in English)
- List of publications
The application must be submitted via the DTU online application system by clicking on the “Apply now” link.
Last Date to Apply:
30th March 2025 (23:59 Danish time)
Applications received after the deadline will not be considered. All interested candidates, regardless of background, are encouraged to apply.
